# AbCellera Biologics Inc. (ABCL): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/abcl for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartere...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $11.37 USD |
| Market Cap | $3.68B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.54 |
| 52-Week Range | $2.75 – $15.02 |
| Dividend Yield (TTM) | — |

## Dividend

ABCL has no dividend payment history in our records.

## Frequently Asked Questions

### What does AbCellera Biologics Inc. do?

AbCellera Biologics Inc. (ABCL) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ABCL's market cap?

AbCellera Biologics Inc. (ABCL) has a market capitalization of approximately $3.68 billion, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does ABCL pay a dividend?

No, AbCellera Biologics Inc. (ABCL) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ABCL profitable?

AbCellera Biologics Inc. (ABCL) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ABCL ever paid a dividend?

No. Dividend Data's records show no dividend payments from AbCellera Biologics Inc. (ABCL). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/abcl
- Dividend history & safety: https://www.dividenddata.com/stocks/abcl/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/abcl/earnings
- Financial statements: https://www.dividenddata.com/stocks/abcl/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/abcl/valuation
- Peer comparison: https://www.dividenddata.com/stocks/abcl/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.